Yearly Archives: 2019

ORPHELIA Pharma announces Orphan Drug Designation granted by FDA for temozolomide in the treatment of neuroblastoma

Newsletter november 2019

It has been a busy year for our Endowment Fund and Corporate Foundation!

Two new projects supported by our Foundation